The authors supported the hypothesis that the immune suppressive functions of CAFs, notably on B cells through the TGF-β pathway, disrupted tumorigenesis in B lymphomas while promoting cancer progression in carcinomas. This evidence concerns the gene TGFB1 and cancer.